Sohliya, A. E. L. (2025) “Revumenib: the newly approved food drug administration drug for the treatment of relapsed acute leukemia with a KMT2A translocation”, International Journal of Research in Medical Sciences, 13(2), pp. 987–988. doi: 10.18203/2320-6012.ijrms20250291.